We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-3.7%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$648M
AUM Growth
-$9.06M
Cap. Flow
+$24M
Cap. Flow %
3.7%
Top 10 Hldgs %
46.83%
Holding
2,692
New
549
Increased
875
Reduced
655
Closed
135

Sector Composition

Rank Sector Weight
1 Financials 14.19%
2 Technology 12.41%
3 Healthcare 4.56%
4 Consumer Discretionary 4.33%
5 Industrials 3.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NOG icon
2026
Northern Oil and Gas
NOG
$2.35B
$2K ﹤0.01%
+73
New +$1.79K
NRG icon
2027
NRG Energy
NRG
$24.8B
$2K ﹤0.01%
58
-53
-48% -$2.07K
NRIX icon
2028
Nurix Therapeutics
NRIX
$2.65B
$2K ﹤0.01%
+116
New +$2.06K
NTB icon
2029
Bank of N.T. Butterfield & Son
NTB
$2.45B
$2K ﹤0.01%
55
NTGR icon
2030
NETGEAR
NTGR
$635M
$2K ﹤0.01%
81
NX icon
2031
Quanex
NX
$1.01B
$2K ﹤0.01%
107
OFG icon
2032
OFG Bancorp
OFG
$2.21B
$2K ﹤0.01%
76
OFIX icon
2033
Orthofix Medical
OFIX
$419M
$2K ﹤0.01%
48
OMAB icon
2034
Grupo Aeroportuario Centro Norte
OMAB
$5.33B
$2K ﹤0.01%
39
OPRA
2035
Opera Ltd
OPRA
$1.79B
$2K ﹤0.01%
370
-1,358
-79% -$8.5K
OPRT icon
2036
Oportun Financial
OPRT
$372M
$2K ﹤0.01%
+133
New +$2.22K
OSPN icon
2037
OneSpan
OSPN
$618M
$2K ﹤0.01%
+123
New +$1.86K
OUT icon
2038
Outfront Media
OUT
$5.5B
$2K ﹤0.01%
+54
New +$1.39K
PAHC icon
2039
Phibro Animal Health
PAHC
$1.39B
$2K ﹤0.01%
+117
New +$2.36K
PCVX icon
2040
Vaxcyte
PCVX
$8.64B
$2K ﹤0.01%
+69
New +$1.51K
PFBC icon
2041
Preferred Bank
PFBC
$1.25B
$2K ﹤0.01%
21
PFSI icon
2042
PennyMac Financial
PFSI
$4.02B
$2K ﹤0.01%
+30
New +$1.81K
PHAT icon
2043
Phathom Pharmaceuticals
PHAT
$692M
$2K ﹤0.01%
+137
New +$2.21K
PLRX icon
2044
Pliant Therapeutics
PLRX
$65M
$2K ﹤0.01%
+224
New +$2.29K
PNTG icon
2045
Pennant Group
PNTG
$1.36B
$2K ﹤0.01%
+126
New +$2.1K
PR
2046
Permian Resources
PR
$16.9B
$2K ﹤0.01%
+291
New +$2.3K
PRLB icon
2047
Protolabs
PRLB
$2.13B
$2K ﹤0.01%
32
+15
+88% +$789
PZZA icon
2048
Papa John's
PZZA
$806M
$2K ﹤0.01%
17
RARE icon
2049
Ultragenyx Pharmaceutical
RARE
$2.55B
$2K ﹤0.01%
28
+4
+17% +$278
RBBN icon
2050
Ribbon Communications
RBBN
$383M
$2K ﹤0.01%
+556
New +$2.28K

Similar funds

Lindbrook Capital's Q1 2022 Portfolio in Review

As of Q1 2022, Lindbrook Capital held 2,692 positions worth $648M, down 1.4% from $657M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Lindbrook Capital deployed $24M of net new capital in Q1 2022, opening 549 new positions and adding to 875 existing holdings. Its largest new stake was Claros Mortgage Trust: 59,524 shares worth $1.02M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Preferred and Income Securities ETF, an estimated $2.13M trimmed.

  • Lindbrook Capital's largest Q1 2022 buy was Claros Mortgage Trust: 59,524 shares worth $1.02M.
  • Lindbrook Capital added most to Apple in Q1 2022, an estimated $2.72M increase.
  • Lindbrook Capital's biggest Q1 2022 reduction was iShares Preferred and Income Securities ETF, cutting an estimated $2.13M.
  • Lindbrook Capital fully exited iShares 1-5 Year Investment Grade Corporate Bond ETF in Q1 2022, selling an estimated $524K.
  • Lindbrook Capital's ten largest holdings make up 47% of its $648M portfolio in Q1 2022.
  • Lindbrook Capital opened 549 new positions and closed 135 in Q1 2022.
  • Lindbrook Capital's portfolio value fell 1.4% quarter-over-quarter to $648M.

Based on Lindbrook Capital's 13F filing for Q1 2022, filed 21 Apr 2022.